Gore, King elected to 2019 IAMBE Class of FellowsMay. 22, 2019, 11:47 AM
by Kelsey Herbers
John Gore, PhD, director of the Vanderbilt University Institute of Imaging Science (VUIIS), and Michael King, PhD, J. Lawrence Wilson Professor and chair of the Department of Biomedical Engineering at Vanderbilt University, were recently elected to the International Academy of Medical and Biological Engineering (IAMBE) 2019 Class of Fellows in recognition of their contributions in the field of medical and biological engineering.
Gore and King are two of 24 inductees from across the globe.
The purpose of the IAMBE, which is affiliated with the International Federation for Medical and Biological Engineering, is to conduct programs that encourage the development of those who are in the early stages of their career. Election to the academy is driven by nominations, which are then screened by the membership committee and voted upon by current fellows.
“I am honored to be one of the 24 fellows to be inducted into the IAMBE this year,” said King. “This is a distinguished group of leaders in the bioengineering field, and it is rewarding for our work to be recognized in this way.”
“I am delighted to be one of a number of imaging scientists recognized, along with Michael King, which confirms the high regard held by others of the biomedical engineering and imaging science programs at Vanderbilt,” said Gore.
Aside from his work establishing and leading VUIIS, which has grown to be one of the leading centers for imaging research in the world, Gore serves as the Hertha Ramsey Cress Professor of Medicine and is a University Professor of Radiology and Radiological Sciences, Biomedical Engineering, Physics and Astronomy, and Molecular Physiology and Biophysics at Vanderbilt University. He is editor-in-chief of the journal Magnetic Resonance Imaging and focuses his research in the development and application of multimodal imaging methods for understanding tissue physiology and structure, molecular imaging and functional brain imaging.
King serves as vice president of the International Society of Bionic Engineering and as editor-in-chief of the Biomedical Engineering Society’s journal Cellular and Molecular Bioengineering. His lab employs tools and concepts from engineering to understand biomedically important processes that occur in the bloodstream, including cancer metastasis, inflammation and thrombosis. Currently, the King Lab is testing novel cancer therapies in mouse models of metastatic breast and prostate cancer through whole-body luminescence imaging.